The global CHO DG44 Media market size is predicted to grow from US$ 386 million in 2025 to US$ 679 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.
CD DG44 Medium is a chemically defined, protein-free medium optimized for the growth of dihydrofolate reductase-deficient (DHFR-) Chinese Hamster Ovary (CHO) cells and the expression of recombinant proteins in suspension culture conditions.
Culture media are a key component in biopharmaceutical manufacturing, aiding cell growth and are the fastest growing segment of the cell culture market. The rapid growth is mainly due to the increasing demand for biomedicine, favorable government policies and increased investment in R&D.
The vaccine and biosimilar markets are on the cusp of tremendous growth, which is also a significant factor driving media growth.
Segmentation by Type
- Serum-Free Media
- Chemically Defined Media
Segmentation by Application
- Universities and Research Institutions
- Biotech Company
- Hospital
- Others
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage
- FUJIFILM Irvine Scientific
- Thermo Fisher Scientific
- Lonza
- Sartorius
- Sigma-Aldrich
Key Questions Addressed in this Report
- What is the 10-year outlook for the global CHO DG44 Media market?
- What factors are driving CHO DG44 Media market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do CHO DG44 Media market opportunities vary by end market size?
- How does CHO DG44 Media break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market